Phase I trial to investigate the effect of renal impairment on isavuconazole pharmacokinetics

PURPOSE: The purpose of the study is to evaluate the effect of renal impairment (RI) and end-stage renal disease (ESRD) on the pharmacokinetics (PK) of isavuconazole and the inactive cleavage product, BAL8728. METHODS: A single intravenous dose of the prodrug isavuconazonium sulfate (372 mg, equival...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Clin Pharmacol
Main Authors: Townsend, Robert W., Akhtar, Shahzad, Alcorn, Harry, Berg, Jolene K., Kowalski, Donna L., Mujais, Salim, Desai, Amit V.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2017
Assuntos:
Clinical Trial
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5423998/
https://ncbi.nlm.nih.gov/pubmed/28271239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-017-2213-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados